Skip to main content

Peer Review reports

From: Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy

Original Submission
20 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Jan 2023 Reviewed Reviewer Report
28 Feb 2023 Reviewed Reviewer Report
28 Mar 2023 Author responded Author comments - Chuan Liu
Resubmission - Version 3
28 Mar 2023 Submitted Manuscript version 3
30 Mar 2023 Author responded Author comments - Chuan Liu
Resubmission - Version 4
30 Mar 2023 Submitted Manuscript version 4
4 Apr 2023 Author responded Author comments - Chuan Liu
Resubmission - Version 5
4 Apr 2023 Submitted Manuscript version 5
11 Apr 2023 Reviewed Reviewer Report
14 Apr 2023 Reviewed Reviewer Report
21 Apr 2023 Reviewed Reviewer Report - Zhitao Chen
5 May 2023 Author responded Author comments - Chuan Liu
Resubmission - Version 6
5 May 2023 Submitted Manuscript version 6
26 Jul 2023 Author responded Author comments - Chuan Liu
Resubmission - Version 7
26 Jul 2023 Submitted Manuscript version 7
Publishing
28 Jul 2023 Editorially accepted
24 Aug 2023 Article published 10.1186/s12885-023-11235-0

You can find further information about peer review here.

Back to article page